Vicarious Surgical (RBOT) Cash from Financing Activities (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Cash from Financing Activities came in at $26000.0 in Q3 2025, up 8.33% quarter-over-quarter from $24000.0 in Q2 2025.
Analysis
Vicarious Surgical (RBOT) Cash from Financing Activities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Cash from Financing Activities for 6 consecutive years, with $26000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $26000.0 in Q3 2025; TTM through Sep 2025 was $73000.0, a 102.78% increase from a year earlier, with the FY2024 full-year figure at $8000.0, down 99.98% from the prior year.
- Cash from Financing Activities was $26000.0 for Q3 2025 at Vicarious Surgical, up from $24000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $191.1 million in Q3 2021 and troughed at -$486000.0 in Q4 2021.
- A 5-year average of $14.5 million and a median of $59000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities slumped 100.14% in 2021 and soared 44133.0% in 2023, its largest moves.
- Over 5 years, Cash from Financing Activities stood at -$486000.0 in 2021, then surged by 1913.17% to $8.8 million in 2022, then sank by 99.61% to $34000.0 in 2023, then sank by 82.35% to $6000.0 in 2024, then surged by 333.33% to $26000.0 in 2025.
- The last three Cash from Financing Activities figures came in at $26000.0 (Q3 2025), $24000.0 (Q2 2025), and $17000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Vicarious Surgical | 476,777.11 | -14.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 44.23 Mn |
| Jun 30, 2023 | 162,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 8.81 Mn |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 59,000.00 |
| Mar 31, 2022 | 174,000.00 |
| Dec 31, 2021 | -486,000.00 |
| Sep 30, 2021 | 191.06 Mn |
| Jun 30, 2021 | 39,000.00 |
| Mar 31, 2021 | 1.55 Mn |
| Dec 31, 2020 | 346.52 Mn |
| Sep 30, 2020 | 346.52 Mn |